RxDoctor Payments Data

Jae-Camille Rosales, PA

Physician Assistant · Las Vegas, NVNPI 1780273920

Payments from drug & device makers

$1,807in general payments, 2019–2025

Across 93 payments — averaging $19.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$585
  • Boehringer Ingelheim$273
  • Novo Nordisk$195
  • AbbVie$147
  • Johnson & Johnson$94
  • Pfizer$74
  • plus $438 from 17 others

What the payments were for

  • Food & beverage$1,807100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,807 in reported general payments places this provider in the 70th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$41,545
Medicare patients
201
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SymbicortBudesonide/Formoterol Fumarate11$3,990
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen146$3,906
Oxycodone Hcl81$962
Albuterol Sulfate HfaAlbuterol Sulfate24$725
Acetaminophen-CodeineAcetaminophen With Codeine13$682
Zolpidem Tartrate130$677
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$590
Atorvastatin Calcium68$586
Gabapentin18$527
Alprazolam91$442
Tramadol Hcl22$302
Levothyroxine Sodium37$285
Amlodipine Besylate35$251
Lisinopril54$240
Losartan Potassium28$226

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaSymbicort$585$3,99011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 881 physician assistant providers in Nevada.

Other physician assistant in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →